Her mother had breast cancer at forty-eight. Her aunt had ovarian cancer. She's been told to keep an eye on it — but no one has ever walked her through what her own risk actually is. Dr. Kelli Peiffer explains what precision medicine means for women, and how genetic testing turns vague risk into an actual plan.

Ask most women what keeps their bones strong, and the answer comes back fast: calcium. But a woman can hit her calcium target every day and still lose bone if her vitamin D is low, her protein intake is thin, or her estrogen has dropped. Dr. Lindsey Cassidy breaks down what bone strength actually depends on — and why the menopause years change the math.

Many women reach their 40s or 50s convinced their metabolism has simply slowed down. A landmark study tracking over 6,400 people found metabolism actually stays remarkably stable from 20 to 60. Dr. Jana Baatenburg breaks down what's really changing in midlife — and why the scale is the least useful number to watch.

She started waking at 2 a.m. for no clear reason — lying there for an hour while her body temperature swung and her thoughts circled. Dr. Sameena Rahman breaks down why midlife sleep disruption isn't a stress problem, and why "it's probably stress" isn't a real answer.

She's sleeping seven hours, exercising four days a week, eating well — and her labs came back "normal." So why does her energy feel like the voltage dropped? Dr. Sameena Rahman explains why standard fatigue workups miss the real story: an interplay between estrogen, cortisol, and thyroid function that a single TSH test can't capture.

For years, women with PCOS navigated a diagnosis that didn't quite add up. The name pointed to the ovaries. The symptoms pointed everywhere else. On May 12, 2026, a global consortium published a landmark paper in The Lancet formally renaming the condition polyendocrine metabolic ovarian syndrome — PMOS. If your care has never quite addressed what you were actually experiencing, the science now agrees with you.

A significant share of LGBTQ+ adults have delayed or avoided necessary medical care because of past experiences with discrimination in healthcare settings. For transgender and nonbinary individuals, that number is higher still. These are not fringe cases. They are patients who needed care and made the calculation that seeking it was too risky.

On May 12, 2026, a paper published in The Lancet formally renamed polycystic ovary syndrome. The condition affecting one in eight women worldwide is now polyendocrine metabolic ovarian syndrome — PMOS. The name change followed 14 years of global collaboration and consensus across 56 organizations. What it reflects clinically, and what it demands from primary care, is worth understanding.

Most women have sat in a doctor's office and decided, at the last moment, not to bring something up. That hesitation is understandable. But it comes at a cost — and it does not have to keep happening.

Most women leave their annual visit with the quiet feeling that something important went unasked. That's not a personal failure — it's a structural one. Here's what a well-women's visit should actually cover, and how to walk in ready to get what you need.

For too long, women were told that what they were feeling was "just part of aging." That era is ending. The conversation around women's hormone health has shifted — and with it, access to real answers, real treatment, and providers who actually listen.

From the launch of Concierge Medicine of the South Shore to new practices opening in Minnesota, Colorado, Michigan, and Cincinnati's third location, 2024 marked a significant chapter in the Ms.Medicine network. Here's what that growth means for women's health — and for the physicians building it.